[Systemic effects of eyedrops].
Le Jeunne
C
C
Service de Médecine Interne II, Hôpital Laennec, Paris.
Hugues
F C
FC
Munera
Y
Y
Haas
C
C
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D009883:Ophthalmic Solutions / Q000009:adverse effects* / Q000494:pharmacology; D010276:Parasympatholytics / Q000009:adverse effects* / Q000494:pharmacology; D010277:Parasympathomimetics / Q000009:adverse effects* / Q000494:pharmacology; D013566:Sympathomimetics / Q000009:adverse effects* / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013566:Sympathomimetics